- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.09. | Simply Solventless Concentrates Ltd: Simply Solventless targets CCAA exit by November | 1 | Stockwatch | ||
| 21.09. | Simply Solventless Concentrates Ltd.: Simply Solventless Outlines Path to Planned CCAA Exit, Announces Approval of $1.0 Million in Rebates, Settlement of Vendor Take-Back Debt, Revocation of Management Cease Trade Order, and Extension of Stay of CCAA Proc | 390 | Newsfile | Calgary, Alberta--(Newsfile Corp. - September 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce a series of milestones and events that collectively chart the... ► Artikel lesen | |
| 02.09. | Simply Solventless files Q2 financials, expects MCTO revocation | 1 | Investing.com | ||
| 01.09. | Simply Solventless Concentrates Ltd Q1 Loss Narrows | 2 | RTTNews | ||
| 31.08. | Simply Solventless Concentrates Ltd: Simply Solventless files Q1 2026 financials | 10 | Stockwatch | ||
| 28.08. | Simply Solventless Concentrates Ltd: Simply Solventless files 2025 results | 3 | Stockwatch | ||
| 27.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Files 2025 Annual Financials and Provides Updates on Timing of Filing Q1 2026 Financials, Management Cease Trade Order, Private Placement and Debt Settlement | 912 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - August 27, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH)... ► Artikel lesen | |
| 24.08. | Simply Solventless Concentrates Ltd: Simply Solventless further delays 2025 results filing | 1 | Stockwatch | ||
| SIMPLY SOLVENTLESS CONCENTRATES Aktie jetzt für 0€ handeln | |||||
| 22.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.316 | Newsfile | Calgary, Alberta--(Newsfile Corp. - August 22, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 15.08. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 1 | Stockwatch | ||
| 15.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.517 | Newsfile | Calgary, Alberta--(Newsfile Corp. - August 14, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 01.08. | Simply Solventless Concentrates Ltd: Simply Solventless delays 2025, Q1 2026 results filing | 3 | Stockwatch | ||
| 01.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.499 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 31, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 29.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Announces CCAA Court Approvals, Secured Debt Amendments and Conversions to Equity, Strong Initial Humble Retrofit Results, Launch of $1.0M Private Placement of Units, and Executive Retirement | 668 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 28, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") is pleased to announce (i) court approval of the transactions (the... ► Artikel lesen | |
| 22.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 903 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 08.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 616 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 7, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless to file 2025 results July 17 | 1 | Stockwatch | ||
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 2 | Stockwatch | ||
| 04.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.295 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 4, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 19.06. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 779 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 18, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES | 40,180 | -0,04 % | Teva/Sanofi: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen | |
| MERCK KGAA | 143,75 | -1,78 % | Milliarden-Hammer: Merck geht aufs Ganze: Dieser Milliarden-Deal könnte alles verändern! | © Foto: Arne Dedert/dpaMerck übernimmt Silence Therapeutics für 1,3 Milliarden US-Dollar. Mit innovativer Gen-Technologie will der Pharmakonzern neue Wachstumsfelder erschließen Enthaltene Werte: DE0006599905Den... ► Artikel lesen | |
| BAYER | 44,150 | -0,14 % | Buy or Goodbye?: Tesla, Totalenergies, Nestle und Bayer - Die Analystenstimmen des Tages | © Foto: Ding Ting/XinHua/dpaTesla, Totalenergies, Nestle und Bayer: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: DE000BAY0017,FR0000120271,CH0038863350,US88160R1014Den vollständigen... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 50,13 | +0,22 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| IAMBIC THERAPEUTICS | 14,520 | -1,02 % | Biotech an der Börse: Iambic-IPO bringt 150 Millionen USD für Krebsmedikamente | Das US-Biotechunternehmen Iambic setzt bei neuen Krebsmedikamenten auf künstliche Intelligenz. Mit dem frischen Börsenkapital will es klinische Studien voranbringen und seine Forschungstechnik ausbauen.... ► Artikel lesen | |
| NOVO NORDISK | 35,210 | +0,18 % | Novo Nordisk muss zittern: Eli Lilly vor Milliardenchance: Neue Abnehmpille nimmt wichtige EU-Hürde! | Eli Lillys Abnehmpille Foundayo nimmt eine wichtige EU-Hürde. Die mögliche Zulassung verschärft den Milliardenwettbewerb mit Novo Nordisk Enthaltene Werte: US5324571083,DK0062498333Den vollständigen... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,130 | 0,00 % | H.C. Wainwright bekräftigt Kaufempfehlung für Aquestive nach FDA-Fortschritten | ||
| GENERATE BIOMEDICINES | 12,800 | +0,08 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| LB PHARMACEUTICALS | 39,460 | +0,10 % | Stifel reiterates Buy rating on LB Pharmaceuticals stock at $53 | ||
| KARDIGAN | 12,740 | 0,00 % | Baird stuft Kardigan mit "Outperform" ein - Kursziel 43 US-Dollar | ||
| OMNIAB | 4,770 | 0,00 % | OmniAb auf der LD Micro Konferenz: Lizenzgebühren, Skalierung und Geduld im Fokus | ||
| BRIGHT MINDS BIOSCIENCES | 52,50 | -0,36 % | Levoit and Cosori: 5 Back to School Wellness Heroes for the Bright Minds of Tomorrow | DUBAI, UAE, Aug. 21, 2026 /PRNewswire/ -- Levoit and Cosori unveil five smart home solutions to tackle back to school stresses: polluted indoor air, relentless AC dryness, post snack floor... ► Artikel lesen | |
| APNIMED | 18,540 | 0,00 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen | |
| SANOFI | 74,16 | -0,64 % | RBC stuft SANOFI auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Sanofi vor Zahlen für das dritte Quartal von 80 auf 75 Euro gesenkt und die Einstufung auf "Sector Perform" belassen. Die Stärke... ► Artikel lesen | |
| ROCHE | 424,02 | -0,33 % | Roche stoppt alle Investitionen in Deutschland | Es läuft im Land. Roche hat sämtliche künftigen Investitionsentscheidungen in Deutschland vorerst auf Eis gelegt. Auslöser ist die Gesundheitspolitik der Bundesregierung. Roche kritisiert zusätzliche... ► Artikel lesen |
SIMPLY SOLVENTLESS CONCENTRATES LTD gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,019 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMPLY SOLVENTLESS CONCENTRATES LTD finden Sie auf Wallstreet Online.